Measuring just 2 mm across and 30 µm thick, Pixium's 'PRIMA' sub-retinal implant is now set to be trialed in patients suffering from central vision blindness caused by dry age-related macular degeneration (AMD) in both the US and France. Image: Pixium Vision. |
© 2024 SPIE Europe |
|